A1497412
3-Bromoimidazo[1,2-<i>b</i>]pyridazine , >98.0% , 18087-73-5
| Pack Size | Price | Stock | Quantity |
| 1G | RMB51.20 | In Stock |
|
| 5G | RMB164.16 | In Stock |
|
| 25G | RMB646.40 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 148.0 to 152.0 °C |
| Density | 1.89 |
| storage temp. | Keep in dark place,Sealed in dry,Room Temperature |
| form | powder to crystal |
| pka | 2.35±0.30(Predicted) |
| color | White to Light yellow |
| InChI | InChI=1S/C6H4BrN3/c7-5-4-8-6-2-1-3-9-10(5)6/h1-4H |
| InChIKey | KJQVHOFAWISYDO-UHFFFAOYSA-N |
| SMILES | C12=NC=C(Br)N1N=CC=C2 |
| CAS DataBase Reference | 18087-73-5 |
Description and Uses
3-Bromoimidazo[1,2-B]pyridazine is a pharmaceutical intermediate compound. It is used in the preparation of Ponatinib, a tyrosine kinase inhibitor (TKI), which is used in the treatment of chronic myeloid leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL).
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H332-H335 |
| Precautionary statements | P280-P305+P351+P338-P310 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| Safety Statements | 24/25 |
| HS Code | 29339900 |

![3-Bromoimidazo[1,2-<i>b</i>]pyridazine](https://img.chemicalbook.com/CAS/GIF/18087-73-5.gif)




![3-ethynylimidazo[1,2-b]pyridazine](https://img.chemicalbook.com/CAS2/GIF/943320-61-4.gif)
![3-Bromoimidazo[1,2-a]pyrimidine](https://img.chemicalbook.com/CAS/GIF/6840-45-5.gif)